MedTrace Logo

MK-0524B Lipid Study (MK-0524B-063)

NCT00479882 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2414

Last updated 2019-02-06

Study results available
· View outcomes & findings →

Summary

This is a 20-week clinical trial in participants with primary hypercholesterolemia or mixed dyslipidemia to demonstrate the effect of MK-0524B compared to MK-0524A + Simvastatin on lipid values.

Conditions

  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia

Interventions

DRUG

Comparator: simvastatin

DRUG

MK-0524A

Extended-release(ER) niacin/Laropiprant (MK-0524) Combination tablet

DRUG

Placebo

DRUG

MK-0524B

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-15
Primary Completion
2008-06-16
Completion
2008-06-16

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00479882 on ClinicalTrials.gov